Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics Statistics

Total Valuation

ARTV has a market cap or net worth of $177.47 million. The enterprise value is $80.40 million.

Market Cap	177.47M
Enterprise Value	80.40M

Important Dates

The next estimated earnings date is Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

ARTV has 24.72 million shares outstanding. The number of shares has increased by 117.11% in one year.

Current Share Class	24.72M
Shares Outstanding	24.72M
Shares Change (YoY)	+117.11%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	8.50%
Owned by Institutions (%)	13.27%
Float	4.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.59
P/TBV Ratio	1.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.61, with a Debt / Equity ratio of 0.10.

Current Ratio	8.61
Quick Ratio	8.31
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -56.55% and return on invested capital (ROIC) is -34.87%.

Return on Equity (ROE)	-56.55%
Return on Assets (ROA)	-32.97%
Return on Invested Capital (ROIC)	-34.87%
Return on Capital Employed (ROCE)	-76.21%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$806,394
Employee Count	104
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +262.63% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+262.63%
50-Day Moving Average	5.38
200-Day Moving Average	3.87
Relative Strength Index (RSI)	62.69
Average Volume (20 Days)	152,869

Short Selling Information

The latest short interest is 148,199, so 0.60% of the outstanding shares have been sold short.

Short Interest	148,199
Short Previous Month	147,133
Short % of Shares Out	0.60%
Short % of Float	3.50%
Short Ratio (days to cover)	0.77

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-89.81M
Pretax Income	-83.87M
Net Income	-83.87M
EBITDA	-87.21M
EBIT	-89.81M
Earnings Per Share (EPS)	-$3.43

Balance Sheet

The company has $108.01 million in cash and $10.94 million in debt, with a net cash position of $97.07 million or $3.93 per share.

Cash & Cash Equivalents	108.01M
Total Debt	10.94M
Net Cash	97.07M
Net Cash Per Share	$3.93
Equity (Book Value)	109.97M
Book Value Per Share	4.53
Working Capital	99.58M

Cash Flow

In the last 12 months, operating cash flow was -$76.75 million and capital expenditures -$2.59 million, giving a free cash flow of -$79.34 million.

Operating Cash Flow	-76.75M
Capital Expenditures	-2.59M
Depreciation & Amortization	2.60M
Net Borrowing	-132,000
Free Cash Flow	-79.34M
FCF Per Share	-$3.21

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARTV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-117.11%
Shareholder Yield	-117.11%
Earnings Yield	-47.26%
FCF Yield	-44.71%

Analyst Forecast

The average price target for ARTV is $18.67, which is 160.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.67
Price Target Difference	160.03%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-24.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1